Sharda Cropchem Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹1,052 Cr +13.2% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
SC

Sharda Cropchem Ltd

Q3 FY26Fertilizers & Agrochemicals

Sharda Cropchem Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,289Cr
+38.8% YoY
+38.8% QoQ
Net profit
₹145Cr
+367.7% YoY
+95.9% QoQ
Margin
19%
+7 pp YoY
+5 pp QoQ
Price₹761
Market cap₹7.1K Cr
P/E11.3

The short version

Expected volume growth of around 15% in FY '27. The company expects volume growth of around 15% for FY '27.

From Sharda Cropchem Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Expected volume growth of around 15% in FY '27.
  • Revenue growth anticipated between 15% to 20% in FY '27.
  • Q4 FY '26 projected as the strongest quarter with demand growth continuing.
  • Growth driven by both new dealers and expanded geographic reach, especially in Europe.
  • Price levels expected to improve gradually, supporting better margins.
  • Strong pipeline with 1,076 product registrations in approval, supporting sustained future growth.

2 more points from Sharda Cropchem Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Planned capital expenditure (capex) for FY '26 is around INR 500 crores, with INR 399 crores already spent in the first 9 months.
  • Capex is aimed at supporting a strong project pipeline, focusing on growth and resilience.
  • For FY '27, capex guidance is estimated to be in the range of INR 450 crores to INR 500 crores, though it could be higher due to uncertainties.
  • The capex primarily supports increasing the global registration pipeline of approximately 1,070 products.

2 more points from Sharda Cropchem Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • As of December 31, 2025, Sharda Cropchem's total product registrations stand at 3,004 globally.
  • There are 1,076 product registration applications currently in the approval pipeline.
  • Regional breakup of pending registrations: Europe - 698, NAFTA - 100, LATAM - 153, Rest of the World - 125.
  • Registration process timelines are uncertain; can range from 1-2 years to even 6-7 years due to regulatory complexities.

2 more points from Sharda Cropchem Ltd's call on order book

Create a free account to keep reading this call

Sharda Cropchem Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Sharda Cropchem Ltd Q3 FY26 results — key figures

Sharda Cropchem Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue1,289929+38.8%929+38.8%
Operating profit (EBITDA)241115+109.6%133+81.2%
Operating margin19%12%+7 pp14%+5 pp
Profit before tax17946+289.1%86+108.1%
Net profit (PAT)14531+367.7%74+95.9%
EPS (₹)16.093.45+366.4%8.24+95.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹92 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries (Q3 FY26)

    114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran

  • Advance Agrolife (Q3 FY26)

    Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways

  • Khaitan Chemical (Q3 FY26)

    Q3-FY26 operational revenue: INR 2,657 million, up 34% year-on-year (Page 23, 24). Key investor presentation takeaways from Khaitan Chemical's Q3 FY26 investor

  • Rama Phosphates (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9] . Key investor presentation takeaways from Rama Phosphates's Q3 FY2

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sharda Cropchem Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sharda Cropchem Ltd Q3 FY26 results?

Expected volume growth of around 15% in FY '27. The company expects volume growth of around 15% for FY '27.

What is Sharda Cropchem Ltd share price analysis?

Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 11.3 with a market cap of ₹7,095 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sharda Cropchem Ltd planning capital expenditure?

Planned capital expenditure (capex) for FY '26 is around INR 500 crores, with INR 399 crores already spent in the first 9 months.

Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.